Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Regularly updating your budget can significantly enhance your financial health by ensuring accurate tracking of income and expenses. Learn more about the benefits.
25,393 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Large holders continue to add ADA as smaller investors trim positions, signaling a strategic shift even as sentiment ...
A sudden pullback in a high-profile space stock captured headlines. This article breaks down the factors behind intui...
Onity Group confirms PHH Mortgage will be renamed Onity Mortgage on March 23, part of a broader brand overhaul tied t...
The Treasury Department will assume management of about $180 billion in defaulted federal student loans, a decisive s...
Ford surprised markets with an upward revision to its 2026 guidance after a solid first quarter. This article breaks ...
A high-profile SpaceX IPO could unleash a broad wave of capex across aerospace, semiconductors, and industrial suppli...
Discover how Claros Mortgage Trust CMTG generates income, navigates rate risk, and positions its portfolio for the ne...
When an asset manager sells million shares of a popular bond ETF, it can signal shifts in liquidity and portfolio str...
Tether is moving deeper into regulatory oversight by enlisting KPMG for its first major audit, signaling a new era fo...
A tech fund placed a sizable bet on a fresh AI chip IPO, wagering roughly $5.8 million. The stock climbed almost 200%...
As AI accelerates, a pair of blue-chip picks stands out for a decade-long hold. Learn why these two AI leaders fit th...